We are live on ! Find out more
ICCM icon

IceCure Medical

13 hedge funds and large institutions have $154K invested in IceCure Medical in 2025 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 0 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 3

8% more funds holding

Funds holding: 1213 (+1)

0% less ownership

Funds ownership: 0.01%0.01% (-0%)

9% less capital invested

Capital invested by funds: $169K → $154K (-$14.9K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 2

Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
Reduced
2
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ICCM Hedge Fund Activity: Q1 2025 in Review

13 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in IceCure Medical (ICCM) for Q1 2025, worth a combined $154K — down 8.8% from $169K a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new ICCM positions and 3 closed out — a net gain of 1 holder — while 0 added to existing stakes and 2 trimmed.

The largest buyer was LPL Financial, opening a new position worth an estimated $24.6K. The largest seller was XTX Topco, cutting an estimated $48.3K.

  • 13 institutional investors held IceCure Medical (ICCM) as of Q1 2025, up from 12 in Q4 2024.
  • Funds reported $154K of IceCure Medical stock for Q1 2025, down 8.8% quarter-over-quarter.
  • 4 funds opened new IceCure Medical positions in Q1 2025 and 3 closed out, a net change of +1 holder.
  • The largest IceCure Medical buyer in Q1 2025 was LPL Financial, an estimated $24.6K added.
  • The largest IceCure Medical seller in Q1 2025 was XTX Topco, an estimated $48.3K sold.

Based on aggregated 13F filings for Q1 2025.